implementing triplet therapy for mhspc: collaboration, patient communication, and qol considerations
Published 13 days ago • 77 plays • Length 5:48Download video MP4
Download video MP3
Similar videos
-
2:27
triplet therapy for metastatic hormone-sensitive prostate cancer
-
4:05
evaluating triplet therapy in metastatic hormone sensitive prostate cancer
-
37:46
systemic therapies for mhspc and castrate resistant prostate cancer
-
16:26
patient selection in metastatic hormone-sensitive prostate cancer (mhspc)
-
3:12
is the triplet regimen standard of care for metastatic castrate-sensitive prostate cancer?
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
15:57
mhspc: chemo-hormonal therapy and treatment intensification
-
13:09
pca commentary: metastatic hormone sensitive prostate cancer (mhspc): many treatment options
-
2:43
update in prostate cancer therapy | upmc
-
2:01
triplet therapy, transplantation, and maintenance in myeloma | nejm
-
2:25
subgroups of metastatic hormone-sensitive prostate cancer (mhspc)
-
1:13
dr. yu on combination therapy for patients with metastatic prostate cancer
-
0:47
systemic triple therapy in metastatic hormone-sensitive prostate cancer
-
20:07
management of mhspc
-
1:34
combination therapies for the treatment of prostate cancer
-
0:37
brachytherapy for prostate cancer
-
3:27
new hope for cancer treatment - 3d-based position control in radiotherapy
-
0:46
radiation therapy for prostate cancer video